The 3rd International Symposium on Kallikreins and Kallikrein-Related Peptidases
Kallikrein-related peptidases
Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis
Kallikrein-related peptidases
Prostate-specific antigen
Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing
Natural and engineered kallikrein inhibitors
Klk8, a multifunctional protease in the brain and skin
Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid*
Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4)
Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors
Dysregulation of kallikrein-related peptidases in renal cell carcinoma
Analysis of an engineered plasma kallikrein inhibitor and its effect on contact activation
Increased blood pressure and water intake in transgenic mice expressing rat tonin in the brain
A structural network associated with the kallikrein-kinin and renin-angiotensin systems*,**
Analyzing the protease web in skin
Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells
KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone
Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides